Clariane SE is a European healthcare group providing care and support services for vulnerable populations. The company operates through two main business segments: elderly care and specialized healthcare. In elderly care, it manages residential facilities for seniors, while in specialized healthcare, it operates hospitals and clinics offering inpatient, day, and outpatient services, including home hospitalization. Clariane serves residents and patients across six European countries: France, Germany, Belgium, Italy, the Netherlands, and Spain. The group operates a network of recognized brands, including Korian, Senior Residencias, Rosorum, Inicea, Grupo 5, and Ita Salud Mental. Founded over twenty years ago, the company focuses on personalized care solutions addressing demographic and epidemiological challenges.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Care Facilities Homepage clariane.com
Sector Healthcare IR page clariane.com/espace-investisseurs
Tags
elderly care, specialized healthcare, hospitalization, home care, senior living, mental health, outpatient services, residential care, Korian, Senior Residencias, Rosorum, Inicea, Grupo 5, Ita Salud Mental
Press page —

Metrics

Valuation  
Market cap € 918.992M
Market cap (USD) $ 1.016B
P/E 992.90
PEG —
P/BV 0.24
P/S 0.15
P/OCF 0.86
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 0.04%
ROI 0.02%
ROIC 4.2%
Profit margin 0.03%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -63.1%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 82.7%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 9
Quality score 43.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue 5.31B 5.282B 4.996B 4.438B 4.311B 3.874B 3.613B
Net profit 1.595M -55.123M -105.245M 22.06M 94.623M 39.402M 114.681M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Share price 3.91 4.16 7.36 7.36 27.32 29.25 —
Price performance 12m -0.06 -0.44 0 -0.73 -0.07 — —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) 315M 365M 440M 565M 457M 411M
↳ YoY growth +15.7% +20.8% +28.3% -19.1% -10.2%
↳ 5y CAGR +5.4%
Borrowings, current (EUR) 952M 681M 948M 1.04B 986M 614M
Borrowings, non-current (EUR) 3.05B 3.76B 3.56B 3.49B 2.98B 3.23B
Lease liabilities (EUR) 3.71B 3.79B 3.76B 4.02B 4.02B 3.97B
Cash and deposits (EUR) 1.16B 1.21B 734M 678M 518M 785M
Intangible assets (EUR) 2.16B 2.19B 2.26B 2.34B 2.34B 2.15B
Right-of-use assets (EUR) 3.46B 3.47B 3.45B 3.65B 3.62B 3.53B
Net debt (borrowings + leases - cash) (EUR) 6.55B 7.01B 7.54B 7.88B 7.46B 7.02B
Cash flow detail
Operating cash flow (EUR) 795M 854M 862M 793M 908M 1.07B
Change in receivables (cash effect) (EUR) 6.4M -24.8M -58.2M 3.42M 55.4M 10.4M
Change in inventories (cash effect) (EUR) -14.2M -2.26M -828,000 -1.44M 1.85M 5.81M
Change in payables (cash effect) (EUR) 29.9M 54.2M 4.6M 73.9M -60M 736,000
Dividends paid (cash effect) (EUR) -10.2M -36.4M -57.8M -65.7M -50.8M -70M
Share buybacks (cash effect) (EUR) — -2.57M -6.47M -493,000 -130,000 —
Interest paid (cash effect) (EUR) — -190M -180M -141M -298M -276M
Income taxes paid (cash effect) (EUR) -66.3M -44.8M -87.4M -40.6M -20M -28.9M
Operating cash flow before change in receivables (EUR) 788M 879M 920M 790M 853M 1.06B
Income detail
Total comprehensive income (EUR) 38.6M 139M 166M -122M -74M 4.25M
Comprehensive income to owners (EUR) 35.9M 117M 154M -132M -76.3M -3.69M
Reported Apr 28, 2022 Apr 27, 2023 Apr 27, 2023 Apr 30, 2024 Mar 31, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Franchissement de seuils et déclaration d'intention Bull 0 Bear 0 Routine
Revenue for the nine months ended September 2026 Bull 3 Bear 0 Results

October 21, 2026 Clariane Group

  • Link copied

Download (PDF, EN, 168.19 KB)

Following the decision handed down yesterday by the Paris Economic Activities Court, the Training and Research Division of the Fondation Œuvre de la Croix Saint-Simon is joining Clariane University. This move brings together the experience and expertise of both organisations to support the provision of healthcare and social care training in Île-de-France, both in initial training, an area of excellence for the Training and Research Division of the Fondation Œuvre de la Croix Saint-Simon, and in continuing professional training, a field in which Clariane University has developed expertise over nearly 10 years.

Due to difficulties affecting some of its activities, the Fondation Œuvre de la Croix Saint-Simon had been placed under judicial reorganisation proceedings in November 2025. Yesterday, the Paris Economic Activities Court selected Clariane University's offer to ensure the continuity of the Training and Research Division.

With seven training institutes and nearly 800 students each year, the division prepares students for careers as nurses, care assistants, childcare auxiliaries, specialist paediatric nurses and social workers. It also offers continuing training for practising professionals.

This move will first and foremost ensure the continuity of the activities of the Training and Research Division of the Fondation Œuvre de la Croix Saint-Simon. All employees will transfer to Clariane University. Existing training programmes, teaching teams and management will be maintained, and the identity of each institute will be preserved. Students will continue their studies under the same conditions and will remain entirely free to choose where they do their placements and who they work for in future, within or outside the Clariane Group.

Beyond ensuring continuity, the partnership also aims to address one of the major challenges facing our healthcare system: the development of healthcare and social care training pathways. Training more care professionals is essential to guarantee everyone access to high-quality care. By combining the teaching experience of Croix Saint-Simon with that of Clariane University, the two teams intend to learn from one another and to strengthen the appeal of these professions together. They also want to multiply the routes into training leading to a qualification throughout working life, for care professionals and for people considering a career change alike. Finally, they wish to develop European exchange opportunities under the Erasmus programme, drawing on the Clariane Group’s presence in Germany, Spain, Italy, Belgium and the Netherlands.

Clariane University, which is structured around three fields — management, care and services — already supports more than 7,700 Clariane Group employees each year who are undertaking diploma programmes, representing 12% of the Group's workforce. It also provides nearly one million hours of continuing training in France, either directly or through partner training centres. 

We are pleased to welcome to Clariane University the teams from the Fondation Œuvre de la Croix Saint-Simon, who have built up remarkable expertise in training care professionals over the years. We will work to uphold this tradition of excellence for the benefit of as many people as possible, students and professionals alike. Faced with the growing need for qualified professionals, those involved in healthcare have an essential role to play in developing skills and preparing the next generation. It is the responsibility of the Clariane Group, as Europe’s leading network providing care for older and vulnerable people, to take an active part in this effort.

Sophie Boissard Chief Executive Officer of the Clariane Group

Training skilled and committed care professionals is essential to meeting the needs arising from an ageing population and the rise in chronic diseases. At the same time, many institutions, both in the hospital sector and in the health and social care sector, are struggling to recruit. By combining our talents, we will be able to train more care professionals, under the best possible conditions, and help care practices evolve. The Croix Saint-Simon division has also developed research activities, and this is an asset: advancing research in the paramedical professions is a priority for us.

Professeur Antoine Piau President of the Clariane University association

I am pleased that Clariane University is taking over the Training and Research Division, which represents a valuable opportunity to highlight the commitment and expertise of the teams and give them the resources to continue and expand their mission: promoting care professions through innovative and meaningful teaching approaches.

Valérie Bouix Leroux Director of the Training and Research Division of the Fondation Œuvre de la Croix Saint-Simon

  • Link copied

Keywords

Pièces-jointes

Press contacts

Nous contacter

  • Florian Bachelet

    Press Relations Manager

  • Mélie Boissonnet

    Press Relations Officer

Home - Clariane

Digital accessibility

Accessibility partially compliant: 81.9% of the RGAA 4 criteria have been met.
Proof of our commitment to digital inclusion.

Find out more

Direct access

Need information?

Follow us on

Copyright Clariane® 2026

Prompts

Clariane SE (ticker CLARI), listed in France.

ETFs Holding Clariane SE

ETF Weight in ETF Shares Market value As of
DISV 0.05% 668,613 $ 2.569M Nov 12, 2026
AVDS 0.03% 31,624 $ 116.625K Nov 16, 2026
DFIS 0.02% 340,898 $ 1.31M Nov 12, 2026
DXIV 0.01% 6,518 $ 25.044K Nov 12, 2026
AVDE 0.01% 275,460 $ 1.016M Nov 16, 2026
AVDV 0.01% 697,500 $ 2.572M Nov 16, 2026
DFIC 0.00% 196,969 $ 756.81K Nov 12, 2026
DFAI 0.00% 156,627 $ 601.805K Nov 12, 2026
DFAX 0.00% 56,980 $ 218.933K Nov 12, 2026
DFSI 0.00% 4,060 $ 15.6K Nov 12, 2026